British Army receives first production Ajax vehicles
Without much fanfare the UK MoD has taken delivery of the first two production standard Ajax Ares variants, Shephard has learnt.
The two vehicles were delivered to the Acceptance and Testing Team for Government Acceptance Tests (GAT) in December 2018. Two further Ares variants are to be delivered by the end of January 2019 and two more in February 2019.
General Dynamics UK (GDUK) also confirmed the vehicle deliveries saying that these would accompany seven prototypes already delivered and undergoing testing.
A total of 589 Ajax platforms are set to be delivered to the British Army through 2017-2024, along with
Already have an account? Log in
Want to keep reading this article?
More from Land Warfare
-
![US Army seeks nearly $900 million to accelerate development and acquisition of CUAS capabilities]()
US Army seeks nearly $900 million to accelerate development and acquisition of CUAS capabilities
The branch plans to speed up the building and procurement of kinetic and non-kinetic systems for fixed, semi-fixed and on-the-move operations.
-
![DroneShield nets largest order ever with $40 million European CUAS contract]()
DroneShield nets largest order ever with $40 million European CUAS contract
The package of three standalone follow-on contracts makes this the largest contract won by the Australian company and larger than its total 2024 revenue.
-
![Patria completes test firing of new self-propelled gun as demand for systems grows]()
Patria completes test firing of new self-propelled gun as demand for systems grows
Patria quotes a maximum rate of fire of eight rounds a minute from the new ARVE (ARtillery on VEhicle) self-propelled gun with a range of 40km for an assisted round. The rapid, low-risk development is designed to meet emerging requirements which have arisen out of the Ukraine war.
-
![US Army modernisation plans raise big concerns for lawmakers]()
US Army modernisation plans raise big concerns for lawmakers
The termination of programmes such as JLTV and RCV has been harshly criticised by members of the US Congress.
